We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Atrial Pacing Reduces Sleep Apnea Episodes

By HospiMedica staff writers
Posted on 26 Feb 2002
An adjustable pacemaker has been found to significantly reduce the number of apnea episodes in patients with sleep apnea, according to a research team headed by Stephane Garrigue, M.D., of the cardiac pacing and clinical electrophysiology department, Cardiology Hospital of Haut-Leveque (Pessac, France). More...
Their study was published in the February 7, 2002, issue of The New England Journal of Medicine.

The study involved 15 patients with central or obstructive sleep apnea who had received permanent atrial-synchronous ventricular pacemakers for symptomatic sinus bradycardia.
All patients underwent a base-line evaluation on the first night, an evaluation of one night in spontaneous rhythm, and an evaluation of one night in dual-chamber pacing mode with atrial overdrive. The latter was 15 beats faster per minute than the mean nocturnal sinus rate. The researchers analyzed and compared the total duration and number of episodes of central or obstructive sleep apnea or hypopnea.

The 24-hour sinus rate during spontaneous rhythm was around 57 beats per minute, with about nine episodes of hypopnea. In contrast, the sinus rate with atrial overdrive pacing was around 72 beats per minute, with about three episodes of hypopnea. For both apnea and hypopnea, the index was about 28 in spontaneous rhythm, compared to about 11 with atrial overdrive pacing. The researchers concluded that the atrial overdrive pacing significantly reduces the number of episodes of central or obstructive sleep apnea without reducing total sleep time.






Related Links:
NEJM

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.